Selective Avoidance of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy In HER-2 Positive/Triple Negative Breast Cancer Patients With Excellent Radiologic Response to the Breast and Axilla, Prospective, Multi-center, Single-arm (ASLAN) Study

NCT04993625 · clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
178
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Jeong Eon Lee

Collaborators